PNEUMOCYSTIS JIROVECII PNEUMONIA
Clinical trials for PNEUMOCYSTIS JIROVECII PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECII PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECII PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Matched conditions: PNEUMOCYSTIS JIROVECII PNEUMONIA
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study seeks best backup plan for deadly pneumonia in immunocompromised patients
Disease control Not yet recruitingThis study looks at which second-choice treatment works best for a serious lung infection called PCP when the usual antibiotic cannot be used due to allergies, side effects, or failure. About 416 adults with weakened immune systems (from HIV, transplants, cancer, or other causes)…
Matched conditions: PNEUMOCYSTIS JIROVECII PNEUMONIA
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a lower dose of antibiotics prevent pneumonia just as well after kidney transplant?
Prevention Not yet recruitingThis study tests whether a lower dose of the antibiotic TMP-SMX works as well as the standard dose to prevent a serious lung infection called PJP in people who have just had a kidney transplant. About 1,084 adult first-time kidney transplant recipients will take either a low or s…
Matched conditions: PNEUMOCYSTIS JIROVECII PNEUMONIA
Phase: PHASE4 • Sponsor: Anhui Provincial Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study tests whether a short course of the steroid prednisolone can prevent paradoxical immune reconstitution inflammatory syndrome (IRIS) in people with AIDS who have low CD4 counts and are starting HIV treatment. About 131 participants will receive either prednisolone or no…
Matched conditions: PNEUMOCYSTIS JIROVECII PNEUMONIA
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC